Lavipharm S.A. reported consolidated and parent earnings results for the second quarter and six months ended June 30, 2012. For the quarter, on the consolidated basis, the company's operating revenues were EUR 8,984,000 compared to EUR 46,131,000 a year ago. LBIT was EUR 119,000 compared to EBIT of EUR 818,000 a year ago. Loss before taxes was EUR 2,119,000 compared to EUR 1,583,000 a year ago. Loss after taxes distributed to shareholders was EUR 2,041,000 compared to EUR 1,226,000 a year ago. Total loss after taxes distributed to shareholders was EUR 3,156,000 compared to EUR 1,164,000 a year ago. Basic loss per share was EUR 0.0400 compared to EUR 0.0240 a year ago. EBITDA was EUR 757,000 compared to EUR 1,794,000 a year ago.

For the six months, on the consolidated basis, the company's operating revenues were EUR 18,989,000 compared to EUR 94,163,000 a year ago. LBIT was EUR 1,161,000 compared to EBIT of EUR 332,000 a year ago. Loss before taxes was EUR 5,435,000 compared to EUR 4,661,000 a year ago. Loss after taxes distributed to shareholders was EUR 4,685,000 compared to EUR 3,543,000 a year ago. Total loss after taxes distributed to shareholders was EUR 5,225,000 compared to EUR 2,677,000 a year ago. Basic loss per share was EUR 0.0917 compared to EUR 0.0694 a year ago. EBITDA was EUR 593,000 compared to EUR 2,183,000 a year ago. Net cash flows from operating activities were EUR 16,087,000 compared to EUR 6,670,000 a year ago. Purchases of tangible and intangible assets were EUR 2,797,000 compared to EUR 547,000 a year ago.

For the quarter, on the company basis, the company's operating revenues were EUR 9,216,000 compared to EUR 11,531,000 a year ago. LBIT was EUR 13,000 compared to EBIT of EUR 446,000 a year ago. Loss before taxes was EUR 551,000 compared to profit before taxes of EUR 95,000 a year ago. Loss after taxes distributed to shareholders was EUR 569,000 compared to profit after taxes distributed to shareholders of EUR 26,000 a year ago. Basic loss per share was EUR 0.0111 compared to basic earnings per share of EUR 0.0005 a year ago. EBITDA was EUR 676,000 compared to EUR 1,108,000 a year ago.

For the six months, on the company basis, the company's operating Revenue was EUR 19,679,000 compared to EUR 24,705,000 a year ago. EBIT was EUR 55,000 compared to EUR 107,000 a year ago. Loss before taxes was EUR 1,014,000 compared to EUR 986,000 a year ago. Loss after taxes distributed to shareholders was EUR 1,040,000 compared to EUR 1,129,000 a year ago. Basic loss per share was EUR 0.0204 compared to EUR 0.0221 a year ago. EBITDA was EUR 1,395,000 compared to EUR 1,433,000 a year ago. Net cash flows from operating activities were EUR 7,540,000 compared to cash out flow of EUR 259,000 a year ago. Purchases of tangible and intangible assets were EUR 2,552,000 compared to EUR 100,000 a year ago.